Theragen Etex Co.,Ltd.

KOSDAQ:A066700 Stock Report

Market Cap: ₩104.0b

Theragen EtexLtd Dividends and Buybacks

Dividend criteria checks 0/6

Theragen EtexLtd does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Why Theragen EtexLtd's (KOSDAQ:066700) Earnings Are Weaker Than They Seem

Nov 26
Why Theragen EtexLtd's (KOSDAQ:066700) Earnings Are Weaker Than They Seem

Lacklustre Performance Is Driving Theragen Etex Co.,Ltd.'s (KOSDAQ:066700) Low P/E

Oct 17
Lacklustre Performance Is Driving Theragen Etex Co.,Ltd.'s (KOSDAQ:066700) Low P/E

Estimating The Fair Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Aug 07
Estimating The Fair Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals

Mar 27
Theragen EtexLtd's (KOSDAQ:066700) Solid Profits Have Weak Fundamentals

Calculating The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Mar 21
Calculating The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Is Theragen EtexLtd (KOSDAQ:066700) A Risky Investment?

Feb 11
Is Theragen EtexLtd (KOSDAQ:066700) A Risky Investment?

Did Theragen EtexLtd's (KOSDAQ:066700) Share Price Deserve to Gain 36%?

Jan 16
Did Theragen EtexLtd's (KOSDAQ:066700) Share Price Deserve to Gain 36%?

A Look At The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

Dec 21
A Look At The Intrinsic Value Of Theragen Etex Co.,Ltd. (KOSDAQ:066700)

We're Not So Sure You Should Rely on Theragen EtexLtd's (KOSDAQ:066700) Statutory Earnings

Nov 23
We're Not So Sure You Should Rely on Theragen EtexLtd's (KOSDAQ:066700) Statutory Earnings

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if A066700's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A066700's dividend payments have been increasing.


Dividend Yield vs Market

Theragen EtexLtd Dividend Yield vs Market
How does A066700 dividend yield compare to the market?
SegmentDividend Yield
Company (A066700)n/a
Market Bottom 25% (KR)1.2%
Market Top 25% (KR)4.0%
Industry Average (Pharmaceuticals)1.0%
Analyst forecast (A066700) (up to 3 years)n/a

Notable Dividend: Unable to evaluate A066700's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A066700's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A066700's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A066700 has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 14:14
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Theragen Etex Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution